Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center
Crossref DOI link: https://doi.org/10.1186/s13741-015-0013-0
Published Online: 2015-02-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bartz, Raquel R
White, William D
Gan, Tong J
License valid from 2015-02-26
Article History
Received: 25 June 2014
Accepted: 28 January 2015
First Online: 26 February 2015